See also this year's filing and all EDGAR filings for this company.
PDF Report 0001177648_2014_Enanta_Pharmaceuticals_INC.pdf
Logs
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'MarketableSecuritiesNoncurrent', 'RestrictedCashAndCashEquivalentsNoncurrent', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'MarketableSecuritiesCurrent', 'AccountsReceivableNetCurrent', 'UnbilledReceivablesCurrent', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'DerivativeLiabilitiesNoncurrent', 'OtherLiabilitiesNoncurrent', 'AccountsPayableCurrent', 'AccruedLiabilitiesCurrent', 'DeferredRevenueCurrent', 'CommonStockValue', 'StockholdersEquity', 'AdditionalPaidInCapital', 'TreasuryStockValue', 'AccumulatedOtherComprehensiveIncomeLossNetOfTax', 'RetainedEarningsAccumulatedDeficit'))"} |
Graph
Absolute values for 0001177648, Enanta Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 104,713,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,121,000 |
| 3 | remainder_Assets | 11,139,000 |
| 4 | LiabilitiesCurrent | 4,526,000 |
| 5 | LiabilitiesNoncurrent | 359,000 |
| 6 | remainder_Liabilities | 1,620,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,183,000 |
| 9 | ResearchAndDevelopmentExpense | 16,841,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 32,053,000 |
| 12 | remainder_NetIncome | 598,000 |
| 13 | remainder_ComprehensiveNetIncome | -12,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 116,973,000 |
| 1 | Liabilities | 6,505,000 |
| 2 | Expenses | 23,024,000 |
| 3 | Revenues | 32,053,000 |
| 4 | StockholdersEquity | 110,468,000 |
| 5 | NetIncome | 9,627,000 |
| 6 | ComprehensiveNetIncome | 9,621,000 |
| 7 | BaseVar | 89,582,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.06 |
| 9 | EconomicCapitalRatio | 4.43 |
Edgar->Model Mapping
Feature Distribution
